drugset / Trial / NCT00272558

Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma

NCT00272558 ↗

Phase 2 Completed 40 enrolled Rigshospitalet, Denmark
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose is to evaluate the activity and feasibility of a two drug regimen which is partly orally and partly intravenous in advanced pleural mesothelioma.

Timeline

Start
2004-09
Primary completion
2009-09
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule — Intravenous
Subject Vinorelbine Small molecule — Intravenous